Literature DB >> 7031502

Biosynthesized products of cultured neuroglial cells: I. Selective release of proteins by cells from human astrocytomas.

P E McKeever, E Quindlen, M A Banks, U Williams, P L Kornblith, S Laverson, M A Greenwood, B Smith.   

Abstract

The proteins synthesized and released by human astrocytoma cells cultured with radiolabeled amino acids were analyzed by polyacrylamide gel electrophoresis in sodium dodecyl sulfate and by trichloracetic acid precipitation. A select group of extracellular proteins was released from the astrocytomas. The most abundant extracellular proteins were at least 250,000 daltons. Five other major proteins (P 175, P 125, P 60, P 47, and P 40) were 175,000, 125,000, 60,000, 47,000, and 40,000 daltons, respectively. The complement of proteins retained by the cells was considerably more complex than those released. Clinical efforts to enhance the immunologic response directed against human astrocytomas must distinguish between extracellular and retained antigens. The pattern of proteins released by gliomas might be diagnostically useful if present in cerebrospinal fluid or serum.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7031502     DOI: 10.1212/wnl.31.11.1445

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  DNA content and marker expression in human glioma explants.

Authors:  R D Davenport; P E McKeever
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

2.  Flowcytometric and cytogenetic analysis of human cultured cell lines derived from high- and low-grade astrocytomas.

Authors:  N Shitara; P E McKeever; J Whang-Peng; T Knutsen; B H Smith; P L Kornblith
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

3.  Products of cells from gliomas: IX. Evidence that two fundamentally different mechanisms change extracellular matrix expression by gliomas.

Authors:  P E McKeever; J Varani; S M Papadopoulos; M Wang; J P McCoy
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

4.  Membrane and cytoplasmic changes in 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU)-sensitive and resistant human malignant glioma-derived cell lines.

Authors:  B H Smith; M Vaughan; M A Greenwood; P L Kornblith; A Robinson; N Shitara; P E McKeever
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

5.  Products of cells cultured from gliomas. VI. Immunofluorescent, morphometric, and ultrastructural characterization of two different cell types growing from explants of human gliomas.

Authors:  P E McKeever; B H Smith; J A Taren; R L Wahl; P L Kornblith; B M Chronwall
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

6.  Effect of differentiation inducers on growth characteristics of human glioma cell lines.

Authors:  L Geder; J W Kreider; J Towfighi; R B Page; R L Ladda; R W Brennan; F Rapp
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

7.  A correlation between serum immunosuppressive acidic protein and altered immunocompetence in patients with brain tumours.

Authors:  K Kikuchi; H Gotoh; M Kowada
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.